This Newly Approved Narcolepsy Drug Is the First to Target the Sleep Disorder's Root Cause Rather Than Its Symptoms
Reported by Smithsonian Magazine ·
Smithsonian Magazine reports: "This Newly Approved Narcolepsy Drug Is the First to Target the Sleep Disorder's Root Cause Rather Than Its Symptoms". The piece connects everyday decisions to their wider environmental and social impact. Read the full story at Smithsonian Magazine for complete details.
Read the full story at Smithsonian Magazine ↗P x BC News curates sustainability journalism. The reporting above belongs to Smithsonian Magazine; the summary is our own. We always link to the original.
Related coverage
- Lifestyle
This week Dyson unveiled its first electric toothbrush
Dezeen
- Lifestyle
Grass-topped Dutch office by Studio Massimo "adds habitat rather than taking it"
Dezeen
- Lifestyle
This 15-Foot Python Is the First Known Snake to Receive Electrochemotherapy for Cancer. Now, She's Officially Free of the Disease
Smithsonian Magazine
- Lifestyle
Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial
Smithsonian Magazine
